{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T18:48:13Z","timestamp":1774723693291,"version":"3.50.1"},"reference-count":31,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["COPD"],"DOI":"10.2147\/copd.s517864","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:30:15Z","timestamp":1749213015000},"page":"1829-1842","source":"Crossref","is-referenced-by-count":1,"title":["Burden of Exacerbations in Patients Newly Initiating an Inhaled Regimen for COPD: A Claims Analysis"],"prefix":"10.2147","volume":"Volume 20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0809-7604","authenticated-orcid":true,"given":"Sanjay","family":"Sethi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4126-2467","authenticated-orcid":true,"given":"Emily","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2100-6148","authenticated-orcid":true,"given":"Vickram","family":"Tejwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lamprey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavita","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trishul","family":"Siddharthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6]]},"reference":[{"key":"ref1","volume-title":"Chronic Obstructive Pulmonary Disease","year":"2023"},{"key":"ref2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2024. Available from: https:\/\/goldcopd.org\/2025-gold-report. Accessed May 27, 2025."},{"key":"ref3","unstructured":"National Heart. Lung, and blood institute. What is COPD?. 2024. Available from: https:\/\/www.nhlbi.nih.gov\/health\/copd. Accessed May 27, 2025."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"5","author":"Soriano","year":"2017","journal-title":"Lancet Respir Med"},{"key":"ref5","unstructured":"American Lung Association. COPD trends brief. 2024. Available from: https:\/\/www.lung.org\/research\/trends-in-lung-disease\/copd-trends-brief. Accessed May 27, 2025."},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0103-2017","volume":"27","author":"Viniol","year":"2018","journal-title":"Eur Respir Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2147\/COPD.S378867","volume":"18","author":"Hanania","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2147\/COPD.S398816","volume":"18","author":"Bogart","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/COPD.S423993","volume":"19","author":"Igboekwe","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref10","unstructured":"Optum. Optum claims data. Available from: https:\/\/www.optum.com\/en\/business\/life-sciences\/real-world-data\/claims-data.html. Accessed May 27, 2025."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"ref13","unstructured":"GlaxoSmithKline. Trelegy Ellipta. (Fluticasone Furoate, Umeclidinium, and Vilanterol Inhalation Powder). GlaxoSmithKline; 2017."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12890-024-03194-4","volume":"24","author":"Anzueto","year":"2024","journal-title":"BMC Pulm Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/COPD.S42366","volume":"8","author":"Yawn","year":"2013","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/jamainternmed.2023.1245","volume":"183","author":"Feldman","year":"2023","journal-title":"JAMA Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"ref18","volume":"55","author":"Halpin","year":"2020","journal-title":"Eur Respir J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2018.09.010","volume":"144","author":"Oshagbemi","year":"2018","journal-title":"Respir Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"791","DOI":"10.18553\/jmcp.2023.22373","volume":"29","author":"Sethi","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"472","DOI":"10.15326\/jcopdf.2024.0515","volume":"11","author":"Krishnan","year":"2024","journal-title":"Chronic Obstr Pulm Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa2401389","volume":"390","author":"Aaron","year":"2024","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/COPD.S89849","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref24","unstructured":"Verona Pharma, plc. Verona pharma announces US FDA approval of ohtuvayre\u2122 (ensifentrine). 2024. Available from: https:\/\/www.veronapharma.com\/news\/verona-pharma-announces-us-fda-approval-of-ohtuvayre-ensifentrine. Accessed May 27, 2025."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","volume":"390","author":"Bhatt","year":"2024","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2303951","volume":"389","author":"Bhatt","year":"2023","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"740803","DOI":"10.3389\/fphar.2021.740803","volume":"12","author":"Facchinetti","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12931-019-1142-7","volume":"20","author":"Singh","year":"2019","journal-title":"Respir Res"},{"key":"ref29","unstructured":"Chiesi Farmaceutici S.p.A. A 52-week, placebo- and active- controlled (roflumilast, daliresp\u00ae 500\u00b5g) study to evaluate the efficacy and safety of two doses of CHF6001 DPI (Tanimilast) as add-on to maintenance triple therapy in subjects with COPD and chronic bronchitis (PILLAR). 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04636814. Accessed May 27, 2025."},{"key":"ref30","unstructured":"Chiesi Farmaceutici S.p.A. A 52-week, placebo-controlled study to evaluate the efficacy and safety of 2 doses of CHF6001 DPI (tanimilast), as add-on to maintenance triple therapy in subjects with COPD and chronic bronchitis (PILASTER). 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04636801. Accessed May 27, 2025."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.18553\/jmcp.2021.20390","volume":"27","author":"Palli","year":"2021","journal-title":"J Manag Care Spec Pharm"}],"container-title":["International Journal of Chronic Obstructive Pulmonary Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/103657","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/103657","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:30:18Z","timestamp":1749213018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/burden-of-exacerbations-in-patients-newly-initiating-an-inhaled-regime-peer-reviewed-fulltext-article-COPD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"URL":"https:\/\/doi.org\/10.2147\/copd.s517864","relation":{},"ISSN":["1178-2005"],"issn-type":[{"value":"1178-2005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}